---  
layout: startup_page  
title: "Avistone Biotechnology"  
id: "en.avistonebio.com"  
permalink: "/avistonebiotechnologyen.avistonebio.com01042024/"  
website: "https://en.avistonebio.com/"  
funding_round: "Series B"  
funding_amount: "$140M"  
investors: "SDIC CS Capital, IDG Capital, Yanchuang Capital, Cathay Capital, Bain Capital"  
about: "Avistone Biotechnology is an oncology company focused on developing innovative therapies for patients with significant unmet medical needs globally. Their lead asset is PLB1001 (Vebreltinib), a small-molecule inhibitor targeting MET tyrosine kinase activity, recently approved in China. The company also has a pipeline of targeted therapies, including PLB1004."  
markets: "Biotechnology Research, Precision Lung Cancer Treatments, Oncology, Pharmaceutical"  
hq: "Beijing, Beijing, China"  
founded_year: ""  
linkedin: "https://www.linkedin.com/company/avistone-biotechnology-co-inc"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/avistone-llc"  
pitchbook: ""  

date_display: "04-Jan-2024"  
date: "2024-01-04"

# SEO Optimization  
meta_title: "Avistone Biotechnology - Series B Funding ($140M)"  
meta_description: "Avistone Biotechnology, Avistone Biotechnology is an oncology company focused on developing innovative therapies for patients with significant unmet medical needs globally. T..."  
meta_keywords: "Avistone Biotechnology, Biotechnology Research, Precision Lung Cancer Treatments, Oncology, Pharmaceutical, Series B funding"  
canonical_url: "https://startup.projectstartups.com/avistonebiotechnologyen.avistonebio.com01042024/"  
---